Sales & Marketing News | pharmaphorum

News

Syneos Health bolsters healthcare communications leadership

Syneos Health has made a series of senior appointments to the leadership of its communications business under new president of communications Tim Pantello.

News

LEO eyeing 2021 US launch for eczema drug tralokinumab

LEO Pharma is gearing up to launch its eczema drug tralokinumab next year after submitting a filing to the FDA, as it bids to take on Sanofi’s class rival Dupixent.

News

Sebastian Mallarino from FCB Health's healthcare communications agency Neon

FCB Health’s Neon appoints Sebastian Mallarino

Sebastian Mallarino has joined FCB Health Network’s Neon agency as its group creative director.

News

Closeup of X-ray photography of human brain

Biogen shares pop as it completes filing for Alzheimer's dru...

Biogen’s share price was up sharply on Wednesday after the big pharma completed its filing of its Alzheimer’s Disease (AD) drug aducanumab with the FDA.

News

Amgen's cancer biosimilars stay on US market as court battle...

Amgen has scored yet another home run in the US courts, this time seeing off a legal challenge from Genentech, which was trying to block it from launching two cut-price cancer biosimilars.

News

FDA grants fast review of AZ's Brilinta to prevent recurring...

The FDA has granted a fast review of AstraZeneca’s cardiovascular diseases drug Brilinta (ticagrelor) in the new indication that aims to reduce the chances of patients having recurring stro

Syneos Health bolsters healthcare communications leadership

LEO eyeing 2021 US launch for eczema drug tralokinumab

FCB Health’s Neon appoints Sebastian Mallarino

Biogen shares pop as it completes filing for Alzheimer's dru...

Amgen's cancer biosimilars stay on US market as court battle...

FDA grants fast review of AZ's Brilinta to prevent recurring...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks